BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12010791)

  • 1. Rescue of the lethal scl(-/-) phenotype by the human SCL locus.
    Sinclair AM; Bench AJ; Bloor AJ; Li J; Göttgens B; Stanley ML; Miller J; Piltz S; Hunter S; Nacheva EP; Sanchez MJ; Green AR
    Blood; 2002 Jun; 99(11):3931-8. PubMed ID: 12010791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective rescue of early haematopoietic progenitors in Scl(-/-) mice by expressing Scl under the control of a stem cell enhancer.
    Sánchez MJ; Bockamp EO; Miller J; Gambardella L; Green AR
    Development; 2001 Dec; 128(23):4815-27. PubMed ID: 11731461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors.
    Sánchez M; Göttgens B; Sinclair AM; Stanley M; Begley CG; Hunter S; Green AR
    Development; 1999 Sep; 126(17):3891-904. PubMed ID: 10433917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.
    Delabesse E; Ogilvy S; Chapman MA; Piltz SG; Gottgens B; Green AR
    Mol Cell Biol; 2005 Jun; 25(12):5215-25. PubMed ID: 15923636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
    Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
    Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the stem cell leukemia (SCL) gene: a tale of two fishes.
    Barton LM; Gottgens B; Gering M; Gilbert JG; Grafham D; Rogers J; Bentley D; Patient R; Green AR
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6747-52. PubMed ID: 11381108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
    Robb L; Lyons I; Li R; Hartley L; Köntgen F; Harvey RP; Metcalf D; Begley CG
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7075-9. PubMed ID: 7624372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
    Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
    Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
    Kallianpur AR; Jordan JE; Brandt SJ
    Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
    Elefanty AG; Robb L; Birner R; Begley CG
    Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
    Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
    Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.
    Bockamp E; Antunes C; Maringer M; Heck R; Presser K; Beilke S; Ohngemach S; Alt R; Cross M; Sprengel R; Hartwig U; Kaina B; Schmitt S; Eshkind L
    Blood; 2006 Sep; 108(5):1533-41. PubMed ID: 16675709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
    Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
    Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct 5' SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: neural expression is mediated by GATA factor binding sites.
    Sinclair AM; Göttgens B; Barton LM; Stanley ML; Pardanaud L; Klaine M; Gering M; Bahn S; Sanchez M; Bench AJ; Fordham JL; Bockamp E; Green AR
    Dev Biol; 1999 May; 209(1):128-42. PubMed ID: 10208748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the stem cell leukemia gene (SCL)--comparative analysis of five vertebrate SCL loci.
    Göttgens B; Barton LM; Chapman MA; Sinclair AM; Knudsen B; Grafham D; Gilbert JG; Rogers J; Bentley DR; Green AR
    Genome Res; 2002 May; 12(5):749-59. PubMed ID: 11997341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene.
    Hall MA; Slater NJ; Begley CG; Salmon JM; Van Stekelenburg LJ; McCormack MP; Jane SM; Curtis DJ
    Mol Cell Biol; 2005 Aug; 25(15):6355-62. PubMed ID: 16024775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.
    Pimanda JE; Silberstein L; Dominici M; Dekel B; Bowen M; Oldham S; Kallianpur A; Brandt SJ; Tannahill D; Göttgens B; Green AR
    Mol Cell Biol; 2006 Apr; 26(7):2615-25. PubMed ID: 16537906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL.
    Elwood NJ; Zogos H; Pereira DS; Dick JE; Begley CG
    Blood; 1998 May; 91(10):3756-65. PubMed ID: 9573012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
    Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
    Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.